Novus Therapeutics – Consensus Indicates Potential 127.3% Upside

Broker Ratings

Novus Therapeutics found using ticker (NVUS) now have 3 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 43 and 27 and has a mean target at 35. Now with the previous closing price of 15.4 this indicates there is a potential upside of 127.3%. There is a 50 day moving average of 15.71 and the 200 moving average now moves to 15.63. The company has a market cap of $21m. Visit the company website at: 0


You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen):

Share on twitter
Share on linkedin
Share on facebook
Share on email
Share on reddit

AIM All Share Index